Affiliations 

  • 1 National Heart Centre Singapore, Singapore, Singapore
  • 2 Mackay Memorial Hospital, Taipei, Taiwan
  • 3 Care Hospital, Hyderabad, India
  • 4 Nippon Medical School's Department of Cardiovascular Medicine, Tokyo, Japan
  • 5 Korea University Hospital, Seoul, Korea
  • 6 Jeffrey Cheah School Of Medicine And Health Sciences, Monash University Malaysia & Department of Cardiology, Queen Elizabeth Hospital 2, Malaysia
  • 7 Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • 8 Manila Doctors Hospital, Manila, Philippines
  • 9 National Cardiovascular Center Universitas Indonesia, Jakarta, Indonesia
  • 10 Heart Centre, Hong Kong Baptist Hospital, Hong Kong, SAR, The People's Republic of China
  • 11 Fuwai Hospital, Beijing, The People's Republic of China
  • 12 Changi General Hospital, Singapore, Singapore
  • 13 Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road Singapore, Singapore 119228
  • 14 Bayer AG, Wuppertal, Germany
  • 15 Medical University of South Carolina, and the Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, SC, USA
  • 16 Veterans Affairs Medical Center, Minneapolis, MN, USA
Eur J Heart Fail, 2019 01;21(1):23-36.
PMID: 30113120 DOI: 10.1002/ejhf.1227

Abstract

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is a global public health problem. Unfortunately, little is known about HFpEF across Asia.

METHODS AND RESULTS: We prospectively studied clinical characteristics, echocardiographic parameters and outcomes in 1204 patients with HFpEF (left ventricular ejection fraction ≥50%) from 11 Asian regions, grouped as Northeast Asia (Hong Kong, Taiwan, China, Japan, Korea, n = 543), South Asia (India, n = 252), and Southeast Asia (Malaysia, Thailand, Singapore, Indonesia, Philippines, n = 409). Mean age was 68 ±12 years (37% were 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.